[{"address1": "Wagistrasse 14", "city": "Schlieren", "zip": "8952", "country": "Switzerland", "phone": "41 44 755 77 00", "fax": "41 44 755 77 07", "website": "https://www.molecularpartners.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Molecular Partners AG, a clinical-stage biotechnology company, designs and develops designed ankyrin repeat proteins therapeutics for the treatment of oncology diseases in Switzerland. Its product pipeline comprises MP0317, which is in Phase 1 clinical trial for the treatment of advanced solid tumors; MP053, novel tetra-specific T cell-engaging DARPin, which is phase 1 clinical trial for the treatment of acute myeloid leukemia; and MP0712, a 212Pb Radio-DARPin therapy (RDT) candidate targeting the tumor-associated protein delta-like ligand 3 (DLL3) which is in preclinical trial to treat SCLC and neuroendocrine tumors. It also researches for Switch-DARPin T cell engager to treat CD3 x costim x; and Radio-DARPin Therapy to treat ovarian disease. In addition, the company develops MP0621, a molecular partners' first Switch-DARPin program, which is in preclinical trial designed to induce killing of hematopoietic stem cells (HSCs) as a next-generation conditioning regimen for HSC transplantation (HSCT); and Radio-DARPin Therapy (RDT) platform, a delivery system for effective and selective delivery of radioactive payloads to solid tumors. It has collaboration agreement with Orano Med SAS to develop novel Radio-DARPin therapeutics and an additional six targeted alpha therapeutics candidates. Molecular Partners AG was incorporated in 2004 and is headquartered in Schlieren, Switzerland.", "fullTimeEmployees": 158, "companyOfficers": [{"maxAge": 1, "name": "Mr. Robert  Hendriks", "title": "Senior VP of Finance", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Renate  Gloggner", "age": 55, "title": "Executive VP of People & Community and Member of Management Board", "yearBorn": 1970, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Philippe  Legenne M.B.A., M.D.", "age": 59, "title": "Chief Medical Officer & Member of the Management Board", "yearBorn": 1966, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Martin  Steegmaier Ph.D.", "title": "Chief Scientific Officer", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michael  Pitzner", "title": "General Counsel, Compliance Officer, Senior VP Legal & Business Development", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Laura  Jeanbart", "title": "Head of Portfolio Management & Corporate Communications", "exercisedValue": 0, "unexercisedValue": 0}], "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 4.1501, "open": 4.25, "dayLow": 4.0925, "dayHigh": 4.25, "regularMarketPreviousClose": 4.1501, "regularMarketOpen": 4.25, "regularMarketDayLow": 4.0925, "regularMarketDayHigh": 4.25, "payoutRatio": 0.0, "beta": 0.587, "forwardPE": -3.0520554, "volume": 2381, "regularMarketVolume": 2381, "averageVolume": 7055, "averageVolume10days": 7500, "averageDailyVolume10Day": 7500, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 158946400, "fiftyTwoWeekLow": 3.36, "fiftyTwoWeekHigh": 5.15, "allTimeHigh": 32.04, "allTimeLow": 3.32, "priceToSalesTrailing12Months": "Infinity", "fiftyDayAverage": 4.22048, "twoHundredDayAverage": 3.90311, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 55957396, "profitMargins": 0.0, "floatShares": 17489339, "sharesOutstanding": 37399152, "sharesShort": 15985, "sharesShortPriorMonth": 20342, "sharesShortPreviousMonthDate": 1765756800, "dateShortInterest": 1768435200, "sharesPercentSharesOut": 0.0004, "heldPercentInsiders": 0.0, "heldPercentInstitutions": 0.09566, "shortRatio": 3.09, "shortPercentOfFloat": 0.00090000004, "impliedSharesOutstanding": 37399152, "bookValue": 3.3346045, "priceToBook": 1.274514, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -60234000, "trailingEps": -2.12, "forwardEps": -1.3925042, "enterpriseToEbitda": -0.986, "52WeekChange": -0.15841585, "SandP52WeekChange": 0.1575526, "quoteType": "EQUITY", "currentPrice": 4.25, "targetHighPrice": 17.542316, "targetLowPrice": 3.889953, "targetMeanPrice": 12.224494, "targetMedianPrice": 12.548527, "recommendationMean": 1.4, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 5, "totalCash": 104521000, "totalCashPerShare": 2.795, "ebitda": -56742000, "totalDebt": 1532000, "quickRatio": 9.081, "currentRatio": 9.28, "totalRevenue": 0, "debtToEquity": 1.604, "revenuePerShare": 0.0, "returnOnAssets": -0.27014, "returnOnEquity": -0.51415, "grossProfits": -40403000, "freeCashflow": -27220124, "operatingCashflow": -53301000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "CHF", "symbol": "MOLN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1769807043, "regularMarketTime": 1769806800, "exchange": "NMS", "messageBoardId": "finmb_32677064", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 2.4071653, "regularMarketPrice": 4.25, "marketState": "CLOSED", "epsTrailingTwelveMonths": -2.12, "epsForward": -1.3925042, "epsCurrentYear": -1.53381, "priceEpsCurrentYear": -2.7708776, "fiftyDayAverageChange": 0.029520035, "fiftyDayAverageChangePercent": 0.0069944733, "twoHundredDayAverageChange": 0.34688997, "twoHundredDayAverageChangePercent": 0.08887527, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-06-16", "averageAnalystRating": "1.4 - Strong Buy", "cryptoTradeable": false, "shortName": "Molecular Partners AG", "longName": "Molecular Partners AG", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1623850200000, "postMarketChangePercent": 0.35336497, "postMarketPrice": 4.26, "postMarketChange": 0.015000343, "regularMarketChange": 0.09989977, "regularMarketDayRange": "4.0925 - 4.25", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 7055, "fiftyTwoWeekLowChange": 0.8900001, "fiftyTwoWeekLowChangePercent": 0.26488099, "fiftyTwoWeekRange": "3.36 - 5.15", "fiftyTwoWeekHighChange": -0.9000001, "fiftyTwoWeekHighChangePercent": -0.1747573, "fiftyTwoWeekChangePercent": -15.841585, "earningsTimestampStart": 1756152000, "earningsTimestampEnd": 1756152000, "earningsCallTimestampStart": 1741345140, "earningsCallTimestampEnd": 1741345140, "isEarningsDateEstimate": false, "trailingPegRatio": null, "__fetch_time": "2026-01-31"}]